Mark Pollack to Drug Therapy, Combination
This is a "connection" page, showing publications Mark Pollack has written about Drug Therapy, Combination.
Connection Strength
0.069
-
An open-label trial of risperidone augmentation for refractory anxiety disorders. J Clin Psychiatry. 2006 Mar; 67(3):381-5.
Score: 0.059
-
Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series. Behav Res Ther. 1999 Aug; 37(8):763-70.
Score: 0.009